-
1دورية أكاديمية
المؤلفون: Mato, Anthony1 (AUTHOR) amato@hackensackumc.org, Feldman, Tatyana1 (AUTHOR), Zielonka, Tania1 (AUTHOR), Singavi, Arun1 (AUTHOR), Gadaletta, Gabriella1 (AUTHOR), Waksmundzki, Kathryn1 (AUTHOR), Bhattacharyya, Pritish1 (AUTHOR), Chow, Kar Fai1 (AUTHOR), Yang, Xiao1 (AUTHOR), Panush, David1 (AUTHOR), Agress, Harry1 (AUTHOR), Rosario, Maria1 (AUTHOR), Howlett, Christina1,2 (AUTHOR), Pecora, Andrew1 (AUTHOR), Goy, Andre1 (AUTHOR)
المصدر: Leukemia & Lymphoma. Dec2013, Vol. 54 Issue 12, p2606-2612. 7p.
مصطلحات موضوعية: *HEALTH outcome assessment, *LYMPHOMA treatment, *DOXORUBICIN, *IMMUNOSUPPRESSIVE agents, *CANCER chemotherapy, *B cell lymphoma
-
2دورية أكاديمية
المؤلفون: Mato, Anthony R., Svoboda, Jakub, Feldman, Tatyana, Zielonka, Tania, Agress, Harry, Panush, David, Miller, Mitchell, Toth, Patrick, Lizotte, Paul M., Nasta, Sunita, Goldberg, Stuart, Chong, Emeline, Schuster, Steven, Pecora, Andrew L., Goy, Andre
المصدر: Cancer (0008543X); Jul2012, Vol. 118 Issue 14, p3565-3570, 6p
مصطلحات موضوعية: POSITRON emission tomography, HEALTH outcome assessment, LYMPHOMA treatment, CANCER patients, CANCER chemotherapy, HODGKIN'S disease, FOLLOW-up studies (Medicine)
-
3دورية أكاديمية
المؤلفون: MATO, ANTHONY R., FELDMAN, TATYANA, GOY, ANDR
المصدر: Oncologist; May2012, Vol. 17 Issue 5, following p694-707, 15p, 2 Diagrams, 4 Charts
مصطلحات موضوعية: THERAPEUTIC use of protease inhibitors, ANTINEOPLASTIC agents, COMBINED modality therapy, IMMUNOTHERAPY, LYMPHOMAS, HEALTH outcome assessment, PROTEASE inhibitors, TREATMENT effectiveness, PHARMACODYNAMICS